EUVIMEDEUVIMED entdecken
Open Access

Smooth Muscle Cell‐Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO‐cGMP Signaling

Susanne Feil iD, Maria T K Zaldivia, Jacek Kiesel, Malte Roessing, Andreas Peter iD, Daniel Morales-Cano iD, Jacob F Bentzon iD, Moritz Lehners, Robert Feil iD

Journal of the American Heart Association · 03.06.2025 · 14 (11)

DOI: 10.1161/jaha.124.040395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.06.2025. Verfasst von Susanne Feil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interfakultäres Institut für Biochemie University of Tübingen Tübingen Germany. Hauptthemen laut MEDLINE: Fibronectins, Myocytes, Smooth Muscle, Muscle, Smooth, Vascular, Cyclic GMP. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronary artery disease due to atherosclerosis is the leading cause of death worldwide. Recent studies revealed an important role of smooth muscle cell (SMC) phenotypic switching in atherogenesis. How the extracellular matrix affects SMC phenotype in atherosclerotic lesions is not well understood. Fibronectin (Fn1) is an abundant component of the extracellular matrix in plaques and has been linked to coronary artery disease risk in humans.

Methods

We used mouse genetics combined with single‐cell analyses, cell lineage tracing, and immunostaining of murine and human atherosclerotic lesions.

Results

Genetic ablation of SMC‐derived Fn1 in mice led to a decrease of alpha smooth muscle actin‐positive cells in atherosclerotic lesions and a reduced collagen content in the fibrous cap indicative of decreased plaque stability. Plaques lacking SMC‐derived Fn1 contained more modulated SMCs with relatively low collagen expression. Interestingly, a subset of the modulated SMCs showed high expression of NO‐sensitive guanylyl cyclase (NO‐GC). NO‐GC is a major cGMP generator in SMCs and like Fn1 has been implicated in coronary artery disease. Fn1 knockout SMCs showed increased cell growth and activity of the NO‐cGMP pathway. Expression of Fn1 and NO‐GC was also detected in modulated SMCs of human atherosclerotic lesions.

Conclusions

SMC‐derived Fn1 promotes plaque stability through suppression of SMC phenotypes with low alpha smooth muscle actin and collagen expression. This atheroprotective effect might be mediated, at least in part, by a crosstalk between Fn1 and the NO‐cGMP axis in SMCs. Our study identifies a mechanistic link between 2 coronary artery disease risk genes, Fn1 and NO‐GC, which explains how the extracellular matrix regulates SMC phenotype and plaque stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibronectinsMyocytes, Smooth MuscleMuscle, Smooth, VascularCyclic GMPNitric OxideAtherosclerosisAnimalsPhenotypeHumansSignal TransductionPlaque, AtheroscleroticMice, KnockoutDisease Models, AnimalMiceActinsMaleCollagenMice, Inbred C57BLCells, CulturedCell Proliferation

Stichwörter der Autor:innen

NO‐cGMP signalingatherosclerosisfibronectinmodulated smooth muscle cellsscRNA‐seqvascular disease

Substanzen

FibronectinsCyclic GMPNitric OxideActinsCollagenFN1 protein, human

Autor:innen und Institutionen

  • Interfakultäres Institut für Biochemie University of Tübingen Tübingen Germany.
  • Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine University Hospital Tübingen Tübingen Germany.
  • Centro Nacional de Investigaciones Cardiovasculares Madrid Spain.
  • Atherosclerosis Research Unit, Department of Clinical Medicine Aarhus University Aarhus Denmark.

ORCID-Profile: Susanne Feil, Andreas Peter, Daniel Morales-Cano, Jacob F Bentzon, Robert Feil

Zitieren

APA

Feil, S., Zaldivia, M. T. K., Kiesel, J., Roessing, M., Peter, A., Morales-Cano, D., Bentzon, J. F., Lehners, M., & Feil, R. (2025). Smooth Muscle Cell‐Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO‐cGMP Signaling. Journal of the American Heart Association, 14(11). https://doi.org/10.1161/jaha.124.040395

Vancouver

Feil S, Zaldivia MTK, Kiesel J, Roessing M, Peter A, Morales-Cano D, et al. Smooth Muscle Cell‐Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO‐cGMP Signaling. Journal of the American Heart Association. 2025;14(11). doi:10.1161/jaha.124.040395

BibTeX
@article{Feil2025,
  author = {Feil, Susanne and Zaldivia, Maria T K and Kiesel, Jacek and Roessing, Malte and Peter, Andreas and Morales-Cano, Daniel and Bentzon, Jacob F and Lehners, Moritz and Feil, Robert},
  title = {Smooth Muscle Cell‐Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO‐cGMP Signaling},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {11},
  doi = {10.1161/jaha.124.040395}
}
Kostenlos starten →